Deficiency of p110δ isoform of the phosphoinositide 3 kinase leads to enhanced resistance to Leishmania donovani.
Visceral leishmaniasis is the most clinically relevant and dangerous form of human leishmaniasis. Most traditional drugs for treatment of leishmaniasis are toxic, possess many adverse reactions and drug resistance is emerging. Therefore, there is urgent need for identification of new therapeutic tar...
Saved in:
Main Authors: | Forough Khadem (Author), Zhirong Mou (Author), Dong Liu (Author), Sanjay Varikuti (Author), Abhay Satoskar (Author), Jude E Uzonna (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD8+ T cells are preferentially activated during primary low dose leishmania major infection but are completely dispensable during secondary anti-Leishmania immunity.
by: Ifeoma B Okwor, et al.
Published: (2014) -
Class-IA Phosphoinositide 3-Kinase p110β Triggers GPCR-Induced Superoxide Production in p110γ-Deficient Murine Neutrophils
by: Kiyomi Nigorikawa, et al.
Published: (2012) -
Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype
by: Peiwei Zhao, et al.
Published: (2024) -
Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
by: Xueqin Huang, et al.
Published: (2023) -
Introduction of pyrrolidineoxy or piperidineamino group at the 4-position of quinazoline leading to novel quinazoline-based phosphoinositide 3-kinase delta (PI3Kδ) inhibitors
by: Minhang Xin, et al.
Published: (2018)